Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)
Clinical trial NCT00511706 · COMPLETED
Trial details
- NCT number
- NCT00511706
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2009-03-01
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.